MedTrace Logo

Pharmacokinetics of Aminocaproic Acid in Scoliosis Surgery

NCT01408823 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 20

Last updated 2013-08-09

No results posted yet for this study

Summary

This study will evaluate the pharmacokinetics of antifibrinolytic drug epsilon-aminocaproic acid (EACA) in children undergoing Posterior spinal fusion surgery (PSF) at The Children's Hospital of Philadelphia (CHOP) who receive EACA at the standard dose reported in the literature for this population and currently in use at CHOP.

Conditions

  • Scoliosis

Sponsors & Collaborators

Principal Investigators

  • Paul Stricker, MD · Children's Hospital of Philadelphia

Eligibility

Min Age
8 Years
Max Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-07-31
Primary Completion
2011-10-31
Completion
2011-10-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01408823 on ClinicalTrials.gov